Large hemangiopericytoma of the pelvis—towards a multidisciplinary approach
© Fard-Aghaie et al. 2015
Received: 13 April 2015
Accepted: 5 August 2015
Published: 28 August 2015
In 1942, Stout described tumors which derive from Zimmerman’s pericytes and suggested the term hemangiopericytoma (HPC). These tumors, which are often highly vascularized, pose difficulties in the surgical management regarding blood loss and complete resection. Therefore, preoperative management seems to be an essential part in dealing with these issues.
We present a 70-year-old female patient with a large HPC in the pelvis. Preoperative embolization of the tumor was performed, and 2 weeks after the intervention, we completely resected the tumor with minimal blood loss.
In which cases do we need preoperative treatment, especially emboliziation of hemangiopericytomas/solid fibrous tumors (SFT)? Although preoperative embolizations of tumors are now commonly undertaken, as for now, neither a clear statement nor a standardized approach has been given or developed. The purpose of this article is to provide our experience with preoperative embolization and to start a new discussion concerning a standardized approach.
Hemangiopericytomas are tumors which derive from Zimmerman’s pericytes. Stout provided the first report and established the term hemangiopericytoma (HPC) . These are now reclassified as solid fibrous tumors. A surgical therapy should involve a multimodal approach, as primary surgery can cause severe blood loss in these highly vascularized tumors. Diagnostic tools like biopsies should be conducted with great caution, if HPCs are considered, as these tumors can lead to exsanguination .
In 1976, Smith et al. described the first case of preoperative embolization of retroperitoneal hemangiopericytomas . Although the resection was successfully undertaken, after this experience, only a handful cases were described which advocated a preoperative treatment prior to surgery. Smullens et al. showed in their report of two patients that a debulking of HPCs, especially concerning the massive blood loss, can be eased using preoperative embolization . In 2000, Morandi et al. published a report of a patient, who was diagnosed with a massive tumor in the mediastinum. Radiological finding suggested a resectable mass. The patient underwent right thoracotomy, but massive bleeding led to the abortion of the procedure and only a biopsy was obtained. The patient lost 2.1 L of blood peroperatively. Subsequently, an arterial embolization was performed. Ten days later, the tumor was resected with minimal blood loss. Therefore, the authors advocated a preoperative embolization of highly vascularized HPCs . Another case of a lipomatous hemangiopericytoma, described by Dozois et al., showed that preoperative embolization, although as described in this case, not as successful as desired, was crucial to perform the debulking .
These cases show that in highly vascularized tumors, especially in HPCs, preoperative arteographic imaging and subsequent embolization, even if only performed partly, reduce preoperative blood loss and increase the chance to perform a radical resection.
The purpose of this article is to begin a new discussion concerning the approach to highly vascularized tumors, especially hemangiopericytomas. As to this date, a standardized approach, which takes these aforementioned aspects into account, does not exist.
The histological finding verified a HPC with a mitotic index of 12 per 10 high-power field. Due to the high probability of local recurrence, we suggested a close monitoring with radiographic assessment. The patient recovered quickly from surgery. A delay of the discharge was due to an uncomplicated wound healing disturbance.
Hemangiopericytomas are highly vascularized large tumors, which arise from pericytes, and are found more commonly in the abdomen or pelvis [7–12]. There are cases which describe tumors in the mediastinum, esophagus, and femur. Even peritoneal carcinomatosis has been seen [5, 13–15]. The symptoms vary from bleeding, extrusion, or pain [16, 17]. HPCs, especially those located in the abdomen, can be as aggressive as angiosarcomas, and metastasis to the bone and lung has also reported [13, 18]. As described before, the potential life threatening blood loss poses a difficult issue for the surgeon. Complete resections of these tumors are often limited due to the fact that viable structures are affected. We believe that preoperative angiographic imaging and subsequent embolization are crucial to guarantee complete resection and concomitantly reduce peroperative morbidity and mortality. The possibility to achieve a complete debulking with free margins can be reached with this approach. In 2012, Asano et al. published a similar case in which prior to the removal of a large HPC an embolization was performed with a good outcome .
Do we change the rate of recurrent disease if we perform a transection of these large tumors, as done in this case? Although, data presented by Espat et al. in 2002 showed with a collective consisting of 25 patients with a follow-up of 49 months metastases in 20 % and local recurrence in 4 % of the resected patients, interestingly, our patient did recur locally and distantly . An effect of the transection cannot be proven, but one must be cautious if transection is performed. The postoperative course after the second operation was uneventful and blood loss minimal. One may ask, why we did not perform embolization of the tumors before the second operation? We think that, unlike highly vascularized, not easily accessible and bulky tumors of the pelvis (like in this case) in liver surgery vascular control is mandatory and inherently part of hepatic resection. Certainly, also the size and the location of the tumor in the liver are vital for the decision to perform transarterial embolization. The size and the location of the hepatic metastases in this case were favorable (Fig. 6). Additionally, the size of the local recurrence was only 3 cm and easily accessible.
In 2015, Manatakis et al. described a case of hepatic metastases of a HPC. In their final statement, they proposed transarterial embolization due to the “hypervascularity of the tumor”. If the case is read carefully, the authors describe a first liver resection without (!) embolization with an uneventful course and state that before the second liver resection, the transarterial embolization was used as tool to “bridge” . Also in 2015, Vetorazzo et al. described a case of a renal HPC without prior embolization with an uneventful resection .
Bokshan et al. showed that even larger resections could be safely performed if in the hands of a dedicated center. In 2012, they published a case of a hepatic metastasized HPC and an ex vivo resection with veno-venous bypass, and reconstruction of the left liver vein with replacement of the inferior vena cava was performed without mortality .
List of recently published case reports with HPCs in the abdomen
Follow-up (in months)
Manatakis et al.
Vetorazzo et al.
Hu et al. 
Bokshan et al.
Asano et al.
Katsuno et al.
Due to the low-incidence of HPCs in the abdomen, a clear statement regarding a preoperative embolization (which localization? which size? or what timing?) cannot be given. We propose following approach for tumors affecting visceral organs in the abdominal cavity:
If the tumor is located in the abdominal cavity/pelvis and is large (a clear value cannot be given but large in the sense of infiltrating or displacing other organs), an embolization needs to be performed. On the other hand, if the location and the size of the tumor are favorable, a hepatic resection can be performed straightaway.
Certainly, the most crucial part of the treatment is a thorough discussion in the MDT.
In our opinion, preoperative embolization should be incorporated into this interdisciplinary approach.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann’s pericytes. Ann Surg. 1942;116(1):26–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Enzinger FM, Smith BH. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976;7(1):61–82.View ArticlePubMedGoogle Scholar
- Smith RB et al. Preoperative vascular embolization as an adjunct to successful resection of large retroperitoneal hemangiopericytoma. J Urol. 1976;115(2):206–8.PubMedGoogle Scholar
- Smullens SN et al. Preoperative embolization of retroperitoneal hemangiopericytomas as an aid in their removal. Cancer. 1982;50(9):1870–5.View ArticlePubMedGoogle Scholar
- Morandi U et al. Preoperative embolization in surgical treatment of mediastinal hemangiopericytoma. Ann Thorac Surg. 2000;69(3):937–9.View ArticlePubMedGoogle Scholar
- Dozois EJ et al. Management of a retrorectal lipomatous hemangiopericytoma by preoperative vascular embolization and a multidisciplinary surgical team: report of a case. Dis Colon Rectum. 2009;52(5):1017–20.View ArticlePubMedGoogle Scholar
- Hobarth K, Hofbauer J, Wrba F. Malignant hemangiopericytoma of the pelvis. Report of a case with urological implications and immunohistochemical analysis. Urol Int. 1991;47(2):94–7.View ArticlePubMedGoogle Scholar
- Imachi M et al. Malignant hemangiopericytoma of the omentum presenting as an ovarian tumor. Gynecol Oncol. 1990;39(2):208–13.View ArticlePubMedGoogle Scholar
- Shiba H et al. Hemangiopericytoma of the greater omentum. J Gastrointest Surg. 2007;11(4):549–51.PubMed CentralView ArticlePubMedGoogle Scholar
- Siniluoto TM et al. Hemangiopericytoma of the kidney: a case with preoperative ethanol embolization. J Urol. 1988;140(1):137–8.PubMedGoogle Scholar
- Vennarecci G et al. Malignant haemangiopericytoma of the mesorectum. Chir Ital. 2004;56(6):865–8.PubMedGoogle Scholar
- West NJ, Daniels IR, Allum WH. Haemangiopericytoma of the sigmoid mesentery. Tech Coloproctol. 2004;8(3):179–81.View ArticlePubMedGoogle Scholar
- Ferigo N et al. Successful treatment via chemotherapy and surgical resection of a femoral hemangiopericytoma with pulmonary metastasis. J Pediatr Hematol Oncol. 2006;28(4):237–40.View ArticlePubMedGoogle Scholar
- Prakash M et al. Hemangiopericytoma: an unusual cause of peritoneal carcinomatosis. Cancer Imaging. 2009;9:32–4.PubMed CentralView ArticlePubMedGoogle Scholar
- Smith RT, Small WC, Mansour K. Case report: haemangiopericytoma of the oesophagus. Br J Radiol. 1995;68(813):1031–3.View ArticlePubMedGoogle Scholar
- Leowardi C et al. Malignant vascular tumors: clinical presentation, surgical therapy, and long-term prognosis. Ann Surg Oncol. 2005;12(12):1090–101.View ArticlePubMedGoogle Scholar
- Grimsley BR, Loggie BW, Goco IR. Hemangiopericytoma: an unusual cause of upper gastrointestinal hemorrhage. Am Surg. 1997;63(3):248–51.PubMedGoogle Scholar
- Hasegawa T et al. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behavior. Hum Pathol. 1999;30(12):1464–73.View ArticlePubMedGoogle Scholar
- Asano N, Nakatani F. A case of hemangiopericytoma of the pelvis. Jpn J Clin Oncol. 2012;42(11):1110.View ArticlePubMedGoogle Scholar
- Espat NJ et al. Conventional hemangiopericytoma: modern analysis of outcome. Cancer. 2002;95(8):1746–51.View ArticlePubMedGoogle Scholar
- Manatakis DK et al. Multidisciplinary approach to hepatic metastases of intracranial hemangiopericytoma: a case report and review of the literature. Case Rep Oncol Med. 2015;2015:214306.PubMed CentralPubMedGoogle Scholar
- Vetorazzo Filho JE et al. Renal hemangiopericytoma: case report and literature review. Einstein (Sao Paulo). 2015;13(2):269–72.View ArticleGoogle Scholar
- Bokshan SL et al. Hepatic hemangiopericytoma/solitary fibrous tumor: a review of our current understanding and case study. J Gastrointest Surg. 2012;16(11):2170–6.View ArticlePubMedGoogle Scholar
- Hu Q et al. Renal hemangiopericytoma secondary to refractory hypertension in a child: a case report. Oncol Lett. 2014;8(6):2493–5.PubMed CentralPubMedGoogle Scholar
- Katsuno H et al. Trans-sacral resection of a solitary fibrous tumor in the pelvis: report of a case. Surg Today. 2011;41(11):1548–51.View ArticlePubMedGoogle Scholar